Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial

Detalles Bibliográficos
Autores principales: Rodenhuis, S, Bontenbal, M, Beex, LVAM, Smit, WM, Nooij, MA, Voest, EE, Wall, E van der, Hupperets, P, Tinteren, Harm van, Peterse, HL, Vijver, MJ van de, Vries, EGE de
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231907/
http://dx.doi.org/10.1186/bcr1227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231907/
http://dx.doi.org/10.1186/bcr1227

Ejemplares similares